Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,293 | 63,727 | 56,767 | 55,103 | 59,197 |
| Marketable Securities | 219,688 | 215,799 | 242,187 | 259,932 | 284,603 |
| Receivables | 29,350 | 35,448 | 30,616 | 32,257 | 31,645 |
| Inventories | 51,022 | 49,285 | 53,153 | 53,839 | 54,007 |
| TOTAL | $369,517 | $375,052 | $394,236 | $413,397 | $444,923 |
| Non-Current Assets | |||||
| PPE Net | 24,376 | 24,146 | 22,127 | 23,102 | 24,794 |
| Intangibles | 331,865 | 332,885 | 333,904 | 334,924 | 335,943 |
| Other Non-Current Assets | 56,607 | 52,000 | 52,891 | 54,047 | 55,129 |
| TOTAL | $412,848 | $409,031 | $408,922 | $412,073 | $415,866 |
| Total Assets | $782,365 | $784,083 | $803,158 | $825,470 | $860,789 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,609 | 20,770 | 16,362 | 15,055 | 14,037 |
| Accrued Expenses | 33,904 | 33,646 | 29,172 | 26,541 | 29,337 |
| Other current liabilities | 1,235 | 2,031 | 1,005 | 2,592 | 5,570 |
| TOTAL | $65,355 | $72,831 | $63,209 | $59,754 | $66,602 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 16,330 | 15,936 | 16,049 | 14,863 | 15,241 |
| Other Non-Current Liabilities | 711,090 | 701,974 | 699,459 | 698,518 | 696,694 |
| TOTAL | $714,644 | $705,903 | $703,859 | $704,227 | $702,549 |
| Total Liabilities | $779,999 | $778,734 | $767,068 | $763,981 | $769,151 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 310,602 | 301,998 | 301,907 | 300,371 | 300,085 |
| Common Shares | 311 | 302 | 302 | 300 | 300 |
| Retained earnings | -2,703,577 | -2,695,302 | -2,654,931 | -2,616,931 | -2,575,001 |
| Other shareholders' equity | -147 | 457 | 415 | 267 | 381 |
| TOTAL | $2,366 | $5,349 | $36,090 | $61,489 | $91,638 |
| Total Liabilities And Equity | $782,365 | $784,083 | $803,158 | $825,470 | $860,789 |